Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 17 results found. Search for [ bacterial infections ]

Results 1-17 of 17
New Delhi, August 19, 2016
"NPPA has fixed/revised ceiling prices of 22 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016 and retail price of 13 formulations under DPCO, 2013," the National Pharmaceutical Pricing Authority (NPPA) said in a statement.
New Delhi, August 1, 2016
"National Pharmaceutical Pricing Authority (NPPA) has fixed/revised ceiling prices of 24 scheduled formulations of schedule-I under Drugs (Price Control) Amendment Order, 2016," the drug pricing regulator said in a order on its website.
New Delhi, June 6, 2016
Prices of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 per cent.
Mail Today Bureau
New Delhi, April 1, 2016
As many as 103 drug formulation packs, including those used for treating bacterial infections, diabetes, high blood pressure, tuberculosis, epilepsy, Hepatitis C and HIV/AIDS, have become cheaper.
E Kumar Sharma
December 15, 2015
In India, much of the problem stems from misuse of antibiotics. For starters, many of are available across the counter at medical stores, though thankfully of late it is becoming difficult at least in some states - such as Maharashtra - where one needs to produce a valid prescription.
E. Kumar Sharma
August 13, 2015
In an interview with E. Kumar Sharma, Ramanan Laxminarayan, Vice President for Research and Policy at the Public Health Foundation of India, discusses the antibiotics scenario and challenges.
Lalit K Jha
Washington, January 31, 2015
The merger deal, once consummated, would create India's largest and world's fifth-biggest drug maker.
Hyderabad, August 15, 2014
The recalled drug bottles were distributed by Caraco Pharmaceutical Laboratories, Ltd in the US while manufactured in India by Sun Pharmaceutical Industries Ltd.
New Delhi, April 14, 2014
According to the information available on the USFDA website, Lupin Pharmaceuticals Inc is recalling two lots of Suprax as the "product did not meet specification in total impurities at the nine-month stability station".
New Delhi, May 4, 2013
Aurobindo Pharma says it has received final approvals from US health regulator to sell generic versions of two separate drugs used for treatment of enlarged prostate and bacterial infections in infants.
New Delhi, December 27, 2012
Aurobindo Pharma says it has received final approval by the US health regulator to manufacture and market Nafcillin for injection used for treating bacterial infections in the American market.
New Delhi, June 5, 2012
Drug maker Lupin on Tuesday said it has received approval from the US health regulator to market its Suprax capsules, used for treating bacterial infections, in the American market.
New Delhi, May 22, 2012
The antibiotic combination of carbapenem and aminoglycoside is to be used for treating bacterial infections.
BT Online Bureau
New Delhi, April 11, 2012
Strides Arcolab plans to immediately launch the product through US-headquartered firm Alvogen on a profit sharing basis.
Anushree Basu
Edition:July 10, 2011
Forget bad hair days as grooming gurus come together to help you sail through the worth weather for your hair-the monsoon. We do a round-up of haircair products on offer to help you opt for the one that works for you.
New Delhi, March 30, 2011
Dr Reddy's Laboratories on Wednesday said it has acquired GlaxoSmithKline's US penicillin manufacturing facility and the rights to the Augmentin and Amoxil brands in the United States for an undisclosed sum.
Nitya Varadarajan
Edition:May 2, 2010
With a near-death experience behind it, Orchid Chemicals prepares to fly again. K. Raghavendra Rao, MD, is as audacious as ever.
PAGES 1 OF 1  
 By Stories    By Author  
From (yyyy-mm-dd)